The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the market in the coming years.
Epigenetics Market Dynamics: Impact Analysis
1. Global Market for Epigenetics: Developed vs Developing Countries
2. Rising Cancer Prevalence
3. Increasing Research Activities
4. Declining Sequencing Costs and Time
5. High Growth Potential in Emerging Markets
6. Growing Applications of Epigenetics in Personalized Medicine
7. Use of Epigenetics in Non-Oncology Applications
The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3%.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global Epigenetics market?
2. What are the drivers, restraints, opportunities, and challenges in the Epigenetics Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Epigenetics in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896
Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle.
Epigenetics Products:
Based on product, the global epigenetics market is segmented into enzymes, instruments and consumables, kits, reagents and bioinformatics tools. The kits segment is expected to grow at the highest CAGR of 16.2% from 2017-2022 due to the fact that a large number of kits are used in various epigenetics techniques. The rising prevalence of a number of diseases, increasing R&D spending, and growing government funding for life science research are further contributing to market growth in this segment.
Applications of Epigenetics:
Oncology is one of those applications where epigenetics technology is extensively used for deriving therapeutic strategies designed to reverse transcriptional abnormalities inherent to the cancer epigenome. The disruption of epigenetic modifications, such as DNA methylation and histone modification, results in altered gene function or expression and cellular transformation leading cancer. Epigenetics assists in the development of inhibitors of DNA methyltransferases and histone deacetylases (HDACs), which have been found to be clinically effective in cancer treatment, attesting to the value of epigenetic therapies in oncology.
Regional Growth Analysis:
The epigenetics market in Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the increasing R&D spending, increasing government initiatives, and rising focus on key market players in the region. Emerging markets such as Brazil, China, and India offer significant growth potential to market players.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=896
Key Players:
The global epigenetics market is characterized by a large number of players. The prominent players of this market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), Bio-Rad (US). These companies are pursuing several organic and inorganic growth strategies such as acquisitions, collaboration, partnerships, agreements, expansions, and product launches.
Epigenetics Market Research: Application (Oncology, Cardiology, Immunology)
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.
Market Research Place has released a new research analysis entitled Global Autoimmune Drugs Market Research Report 2019-2025 provides deep analysis on market-size, shares supply-demand analysis, sales value and volume study of Autoimmune Drugs industry.
The report studies top players with their company profile, growth aspects, opportunities, and threats to market development.
The report covers the current evolution inside the world trade and crucial parts that affect the expansion of the market.
It offers a dynamic vision of the global scenario in terms of market size, market statistics, and the competitive situation.Market Overview:The industry overview portion of the report provides the growth analysis and historical & futuristic cost, revenue, demand and supply data.
It offers readers a holistic view of the global market.
An analysis of the industrial chain, current market fluctuations, and analysis of customers has been served in the report.DOWNLOAD FREE SAMPLE REPORT: https://www.marketresearchplace.com/report-detail/182839/request-sampleKey Points Covered In This Autoimmune Drugs Market Report:Executive Summary: It provides market size with 2018 as the base year in consideration and a yearly forecast until 2025 in terms of revenue (USD Million).Market Dynamics: Key factors that are anticipated to considerably drive or limit the market’s growth are clarified in this research study.
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.
Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).
To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this link The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:Application AreaCardiac ScanningEmergency MedicinesGynecological / Obstetrics ScanningMusculoskeletal ScanningPulmonary ScanningUrological ScanningVascular SurgeryOther Application Areas Type of Transducer ArrayCurvedEndocavityLinearPhasedOther Scanners Type of SoftwareSmartphone ApplicationsCustomized Software End-UsersAmbulatory Surgical CentersDiagnostic Imaging CentersHospitalsMaternity ClinicsSpecialty ClinicsOther End-Users Key Geographical Regions North AmericaEuropeAsia-Pacific and the Rest of the World The Global Handheld Ultrasound Imaging Devices Market, 2020-2030, report features the following companies, which we identified to be key players in this domain: Aidmax MedicalBeijing Konted Medical TechnologyBiim UltrasoundBreastITButterfly NetworkCJ MedicalClarius Mobile HealthEchoNousFujifilmGE HealthcareGuangzhou Top Medical EquipmentHealcerionInterson Medical InstrumentsPhilipsSomax SystemsVINNOWuHan Youkey Bio-Medical ElectronicsYor Labs Table of Contents Preface 2.
Executive Summary Introduction Market Landscape Company Profiles Brand Positioning Analysis of Key Players Partnerships and Collaborations Cost Saving Analysis Demand Analysis Market Forecast End-User Specific Opportunity Analysis Case Study: Impact of Coronavirus Outbreak Conclusion Executive Insights Appendix 1: Tabulated Data Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]
Market Research Place has released a new research analysis entitled Global Autoimmune Drugs Market Research Report 2019-2025 provides deep analysis on market-size, shares supply-demand analysis, sales value and volume study of Autoimmune Drugs industry.
The report studies top players with their company profile, growth aspects, opportunities, and threats to market development.
The report covers the current evolution inside the world trade and crucial parts that affect the expansion of the market.
It offers a dynamic vision of the global scenario in terms of market size, market statistics, and the competitive situation.Market Overview:The industry overview portion of the report provides the growth analysis and historical & futuristic cost, revenue, demand and supply data.
It offers readers a holistic view of the global market.
An analysis of the industrial chain, current market fluctuations, and analysis of customers has been served in the report.DOWNLOAD FREE SAMPLE REPORT: https://www.marketresearchplace.com/report-detail/182839/request-sampleKey Points Covered In This Autoimmune Drugs Market Report:Executive Summary: It provides market size with 2018 as the base year in consideration and a yearly forecast until 2025 in terms of revenue (USD Million).Market Dynamics: Key factors that are anticipated to considerably drive or limit the market’s growth are clarified in this research study.
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.
Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).
To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this link The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:Application AreaCardiac ScanningEmergency MedicinesGynecological / Obstetrics ScanningMusculoskeletal ScanningPulmonary ScanningUrological ScanningVascular SurgeryOther Application Areas Type of Transducer ArrayCurvedEndocavityLinearPhasedOther Scanners Type of SoftwareSmartphone ApplicationsCustomized Software End-UsersAmbulatory Surgical CentersDiagnostic Imaging CentersHospitalsMaternity ClinicsSpecialty ClinicsOther End-Users Key Geographical Regions North AmericaEuropeAsia-Pacific and the Rest of the World The Global Handheld Ultrasound Imaging Devices Market, 2020-2030, report features the following companies, which we identified to be key players in this domain: Aidmax MedicalBeijing Konted Medical TechnologyBiim UltrasoundBreastITButterfly NetworkCJ MedicalClarius Mobile HealthEchoNousFujifilmGE HealthcareGuangzhou Top Medical EquipmentHealcerionInterson Medical InstrumentsPhilipsSomax SystemsVINNOWuHan Youkey Bio-Medical ElectronicsYor Labs Table of Contents Preface 2.
Executive Summary Introduction Market Landscape Company Profiles Brand Positioning Analysis of Key Players Partnerships and Collaborations Cost Saving Analysis Demand Analysis Market Forecast End-User Specific Opportunity Analysis Case Study: Impact of Coronavirus Outbreak Conclusion Executive Insights Appendix 1: Tabulated Data Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.